Silo Pharma, Inc.
SILO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,918 | $4,334 | $3,137 | $3,906 |
| Short-Term Investments | $2,021 | $1,926 | $2,315 | $3,175 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $226 | $113 | $153 | $31 |
| Total Curr. Assets | $6,164 | $6,373 | $5,604 | $7,111 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $220 | $223 | $238 | $241 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $56 | $58 | $59 |
| Total NC Assets | $220 | $279 | $296 | $300 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,385 | $6,653 | $5,900 | $7,412 |
| Liabilities | – | – | – | – |
| Payables | $636 | $978 | $1,113 | $1,584 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $72 | $72 | $72 | $72 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $708 | $1,050 | $1,185 | $1,656 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $668 | $686 | $704 | $722 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $668 | $686 | $704 | $722 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,376 | $1,735 | $1,889 | $2,378 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$18,611 | -$17,500 | -$16,296 | -$15,265 |
| AOCI | $11 | $10 | $11 | $2 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5,009 | $4,917 | $4,011 | $5,034 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,385 | $6,653 | $5,900 | $7,412 |
| Net Debt | -$3,918 | -$4,334 | -$3,137 | -$3,906 |